Lupin and Galenicum sign license and supply agreement for Semaglutide in 23 Countries
Lupin announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings SA (LAHSA) with Galenicum Health,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GLP-1
Needles, pens and pressure: The GLP-1 challenge
The rapid global adoption of GLP-1 based therapies, developed for diabetes and now also used for weight management, has reshaped…
Will India pass the cough syrup trust test this time?
While India’s CDMOs are well positioned to capitalise on the booming GLP-1 market, the recurring episodes of contaminated cough…
OneSource pharma launches new brand identity at CPHI, Milan
OneSource Pharma targets biologics and drug-device markets with end-to-end solutions and global expansion
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist…
Benemae’s benaglutide injection (Feisumei) was the first innovator approved for obesity in July 2023 in China followed by Novo…